6pjn
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==HIV-1 Protease NL4-3 WT in Complex with LR2-41== | ==HIV-1 Protease NL4-3 WT in Complex with LR2-41== | ||
- | <StructureSection load='6pjn' size='340' side='right'caption='[[6pjn]]' scene=''> | + | <StructureSection load='6pjn' size='340' side='right'caption='[[6pjn]], [[Resolution|resolution]] 1.98Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PJN OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6PJN FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6pjn]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PJN OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6PJN FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6pjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6pjn OCA], [http://pdbe.org/6pjn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6pjn RCSB], [http://www.ebi.ac.uk/pdbsum/6pjn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6pjn ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=OQP:(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl+[(2S,3S,5S)-3-hydroxy-5-({1-[(methoxycarbonyl)amino]cyclopentane-1-carbonyl}amino)-1,6-diphenylhexan-2-yl]carbamate'>OQP</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">pol ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 9HIV1])</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6pjn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6pjn OCA], [http://pdbe.org/6pjn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6pjn RCSB], [http://www.ebi.ac.uk/pdbsum/6pjn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6pjn ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The design, synthesis, and X-ray structural analysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseudo-C2-symmetric dipeptide isostere are described. A series of PIs were synthesized by incorporating bis-THF of darunavir on either side of the Phe-Phe isostere of lopinavir in combination with hydrophobic amino acids on the opposite P2/P2' position. Structure-activity relationship studies indicated that the bis-THF moiety can be attached at either the P2 or P2' position without significantly affecting potency. However, the group on the opposite P2/P2' position had a dramatic effect on potency depending on the size and shape of the side chain. Cocrystal structures of inhibitors with wild-type HIV-1 protease revealed that the bis-THF moiety retained similar interactions as observed in the darunavir-protease complex regardless of position on the Phe-Phe isostere. Analyses of cocrystal structures and molecular dynamics simulations provide insights for optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isosteres. | ||
+ | |||
+ | Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-Tetrahydrofuran in a Pseudo-Symmetric Dipeptide Isostere.,Rusere LN, Lockbaum GJ, Henes M, Lee SK, Spielvogel E, Rao DN, Kosovrasti K, Nalivaika EA, Swanstrom R, Kurt Yilmaz N, Schiffer CA, Ali A J Med Chem. 2020 Jul 16. doi: 10.1021/acs.jmedchem.0c00529. PMID:32672965<ref>PMID:32672965</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 6pjn" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Ali A]] | + | [[Category: Ali, A]] |
- | [[Category: Henes M]] | + | [[Category: Henes, M]] |
- | [[Category: Kosovrasti K]] | + | [[Category: Kosovrasti, K]] |
- | [[Category: KurtYilmaz N]] | + | [[Category: KurtYilmaz, N]] |
- | [[Category: Lee | + | [[Category: Lee, S K]] |
- | [[Category: Lockbaum | + | [[Category: Lockbaum, G J]] |
- | [[Category: Nalivaika | + | [[Category: Nalivaika, E A]] |
- | [[Category: Rusere | + | [[Category: Rusere, L N]] |
- | [[Category: Schiffer | + | [[Category: Schiffer, C A]] |
- | [[Category: Spielvogel E]] | + | [[Category: Spielvogel, E]] |
- | [[Category: Swanstrom R]] | + | [[Category: Swanstrom, R]] |
+ | [[Category: Drug resistance]] | ||
+ | [[Category: Hiv]] | ||
+ | [[Category: Hydrolase]] | ||
+ | [[Category: Hydrolase inhibitor complex]] | ||
+ | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
+ | [[Category: Nl4-3 protease]] | ||
+ | [[Category: Protease inhibitor]] |
Revision as of 11:25, 26 August 2020
HIV-1 Protease NL4-3 WT in Complex with LR2-41
|
Categories: Large Structures | Ali, A | Henes, M | Kosovrasti, K | KurtYilmaz, N | Lee, S K | Lockbaum, G J | Nalivaika, E A | Rusere, L N | Schiffer, C A | Spielvogel, E | Swanstrom, R | Drug resistance | Hiv | Hydrolase | Hydrolase inhibitor complex | Hydrolase-hydrolase inhibitor complex | Nl4-3 protease | Protease inhibitor